Literature DB >> 11447345

Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity.

S J Wang1, T S Sihra, P W Gean.   

Abstract

Lamotrigine (LAG) is an antiepileptic drug which is believed to suppress seizures by inhibiting the release of excitatory neurotransmitters. The present study was aimed at investigating the effect of LAG on the 4-aminopyridine (4AP)-evoked glutamate release in cerebrocortical nerve terminals (synaptosomes). LAG inhibited the release of glutamate evoked by 4AP in a concentration-dependent manner. This inhibitory effect was associated with a reduction in the depolarization-evoked increase in the cytoplasmic free Ca2+ concentration ([Ca2+]C). In addition, LAG did not alter the resting synaptosomal membrane potential or 4AP-evoked depolarization. Furthermore, ionomycin-evoked glutamate release was not affected by LAG. Based on these results, we suggest that presynaptic calcium influx blockade and inhibition of glutamate release may underlie the mechanism of action of LAG. These action may also contribute to their neuroprotective properties in excitotoxic injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447345     DOI: 10.1097/00001756-200107200-00042

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

1.  A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.

Authors:  E Sherwood Brown; Prabha Sunderajan; Lisa T Hu; Sharon M Sowell; Thomas J Carmody
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response.

Authors:  Jon E Grant; Brian L Odlaug; Samuel R Chamberlain; Suck Won Kim
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

3.  Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus.

Authors:  Giuseppe Tringali; Jean Michel Aubry; Pierluigi Navarra; Giacomo Pozzoli
Journal:  Psychopharmacology (Berl)       Date:  2006-09-01       Impact factor: 4.530

Review 4.  Update on pathological skin picking.

Authors:  Jon E Grant; Brian L Odlaug
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

5.  Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats.

Authors:  Chia-Ho Lin; Chia-Ching Lee; Ya-Chun Huang; Su-Jane Wang; Po-Wu Gean
Journal:  Learn Mem       Date:  2005-03-17       Impact factor: 2.460

6.  Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats.

Authors:  Shagufta Ahmad; Leslie J Fowler; Peter S Whitton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-20       Impact factor: 3.000

Review 7.  Glutamatergic medications for the treatment of drug and behavioral addictions.

Authors:  M Foster Olive; Richard M Cleva; Peter W Kalivas; Robert J Malcolm
Journal:  Pharmacol Biochem Behav       Date:  2011-04-22       Impact factor: 3.533

8.  Comparison and effects of acute lamotrigine treatment on extracellular excitatory amino acids in the hippocampus of PTZ-kindled epileptic and PTZ-induced status epilepticus rats.

Authors:  Yan Deng; Minghuan Wang; Wei Wang; Chao Ma; Nongyue He
Journal:  Neurochem Res       Date:  2012-12-11       Impact factor: 3.996

9.  Attenuation of the effects of corticosteroids on declarative memory with lamotrigine.

Authors:  E Sherwood Brown; Justin Wolfshohl; Mujeeb U Shad; Miguel Vazquez; I Julian Osuji
Journal:  Neuropsychopharmacology       Date:  2007-11-14       Impact factor: 7.853

10.  Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses.

Authors:  Yong-Hong Yi; Wen-Chao Guo; Wei-Wen Sun; Tao Su; Han Lin; Sheng-Qiang Chen; Wen-Yi Deng; Wei Zhou; Wei-Ping Liao
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.